Inui 1999.
| Study characteristics | ||
| Methods | Randomised controlled trial Run‐in period: not specified. Received November 1998; revised February 1999. Published 1999 Number of study centres and location: not specified |
|
| Participants | Twenty‐four participants were assessed in this study. Inclusion criteria: adult patients undergoing cardiac surgery |
|
| Interventions | Intervention: Duraflo II heparin‐coated CPB circuits Control: uncoated circuit |
|
| Outcomes | TNF‐α, IL‐6, IL‐8, MPO, TAT, PIC, TM | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Low risk | Twenty‐four patients were randomly assigned to be investigated. Nine participants underwent CABG, and 15 underwent valve replacement or valve repair surgery. |
| Allocation concealment (selection bias) | Unclear risk | No details given |
| Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | No details given |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No details given |
| Incomplete outcome data (attrition bias) All outcomes | Low risk | All data included in analysis |
| Selective reporting (reporting bias) | Low risk | No reporting bias apparent |
| Other bias | Unclear risk | No details given |